Agilent Technologies’ (A) Outperform Rating Reiterated at Sanford C. Bernstein

Posted by Francis Steltz on Jun 26th, 2026

Agilent Technologies (NYSE:A – Get Free Report)‘s stock had its “outperform” rating reiterated by stock analysts at Sanford C. Bernstein in a research report issued to clients and investors on Friday,Benzinga reports. They currently have a $155.00 price target on the medical research company’s stock. Sanford C. Bernstein’s target price would suggest a potential upside of 14.20% from the company’s previous close.

Several other research analysts also recently weighed in on the company. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. HSBC cut their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Royal Bank Of Canada started coverage on Agilent Technologies in a research report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 target price on the stock. Robert W. Baird increased their price target on shares of Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a report on Tuesday, May 26th. Finally, Wells Fargo & Company reduced their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, May 28th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Agilent Technologies has an average rating of “Moderate Buy” and a consensus price target of $160.88.

Check Out Our Latest Stock Report on A

Agilent Technologies Stock Up 3.1%

Agilent Technologies stock opened at $135.73 on Friday. The firm has a 50 day moving average price of $122.53 and a 200-day moving average price of $126.25. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. Agilent Technologies has a twelve month low of $108.35 and a twelve month high of $160.27. The company has a market capitalization of $38.33 billion, a P/E ratio of 27.25, a P/E/G ratio of 2.34 and a beta of 1.26.

Agilent Technologies (NYSE:A – Get Free Report) last posted its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company had revenue of $1.83 billion for the quarter, compared to analysts’ expectations of $1.80 billion. During the same quarter in the previous year, the firm posted $1.31 EPS. Agilent Technologies’s revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, equities analysts predict that Agilent Technologies will post 6 EPS for the current year.

Institutional Investors Weigh In On Agilent Technologies

A number of hedge funds have recently made changes to their positions in A. Core Wealth Advisors LLC purchased a new stake in shares of Agilent Technologies in the 4th quarter valued at $26,000. SHP Wealth Management bought a new position in shares of Agilent Technologies during the fourth quarter valued at about $26,000. Board of the Pension Protection Fund purchased a new position in shares of Agilent Technologies in the fourth quarter worth about $27,000. Navalign LLC bought a new stake in shares of Agilent Technologies in the 4th quarter valued at about $27,000. Finally, Cedar Mountain Advisors LLC bought a new stake in shares of Agilent Technologies in the 1st quarter valued at about $27,000.

Agilent Technologies Company Profile

(Get Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.